scorecardresearch
Friday, March 29, 2024
Support Our Journalism
HomeIndiaDCGI claims India on course to become global drugs hub

DCGI claims India on course to become global drugs hub

Follow Us :
Text Size:

By Shalini Bhardwaj

New Delhi [India], April 14 (ANI): Claiming that India is on course to become a ‘global hub for medicines’, Dr VG Somani, Drug Controller General of India (DCGI), said that there has been a fourfold increase in applications of the investigational new drugs in the country.

Speaking at the Indian Drug Manufacturers’ Association (IDMA) Annual Conclave, Somani said, “We are getting the applications of the investigational new drugs. Earlier, there used to be hardly 5-10 applications. At present, there are 23 applications in the pipeline for the investigational new drug and this is a great achievement of our country.”

He said that the “Made in India” drugs will make a difference and hit the world in the coming years.

The DCGI official also explained how drug controllers work while taking decisions about vaccines and drugs.

“We have been in regular contact with the WHO and all regulators of the world through ICMR, ICH platform etc. There are various platforms for the approval of vaccines and drugs including trials. That’s what we have done with remdesivir. There is no single platform for decisions to be taken,” he added.

He further said that India has been recognised as a “Pharmacy of the world” and added “we want to become the well-managed pharmacy of the entire world so that our potential can be recognised”. (ANI)

This report is auto-generated from ANI news service. ThePrint holds no responsibility for its content.

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

  • Tags

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular